| Boston Orthotics & Prosthetics | |
| 541 Main St, Ste 214, Weymouth, Massachusetts 02190 | |
| (781) 849-0247 |
| Name | Boston Orthotics & Prosthetics |
|---|---|
| Organization Name | Boston Brace International Inc. |
| Location | 541 Main St, Ste 214, Weymouth, Massachusetts 02190 |
| Type | Prosthetic/Orthotic Supplier |
| Phone | (781) 849-0247 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Treating people with advanced metastatic kidney cancer using a combination of the immunotherapy drugs nivolumab (Opdivo) and ipilimumab (Yervoy) significantly increased overall survival versus treatment with sunitinib (Sutent) alone, according to new findings from researchers at Memorial Sloan Kettering Cancer Center that were reported today in the New England Journal of Medicine.
Data show that treatment with a single-pill combination of telmisartan, an angiotensin receptor blocker, (ARB) and amlodipine, a calcium channel blocker (CCB) results in significant reductions in blood pressure (BP) in patients with severe hypertension.
NovaBay Pharmaceuticals, Inc. today announced that its lead product candidate was safe and efficacious against the highly contagious skin infection impetigo in a Phase 2a proof-of-concept clinical trial. This dose-ranging study showed that the drug cleared impetigo infections, including those in the trial caused by a drug-resistant strain of bacteria called methicillin-resistant Staphylococcus aureus or MRSA. Impetigo afflicts approximately 1 million people, primarily infants and children, in the United States annually.
The Advanced Wound Management Division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc invites those attending the upcoming Symposium on Advanced Wound Care to visit the Smith & Nephew booth 301, to see the ALLEVYN™ difference with its unique triple-action technology and dynamic moisture control.
As the holidays draw to a close, 29 million Americans with type 2 diabetes had to navigate the minefield of treats, drinks, and dinners. Many patients have stepped up to meet the challenge of moderating their diet, but fewer embrace the benefits of physical activity in controlling their blood sugar.
› Verified 8 days ago
| NPI Number | 1518162619 |
| Organization Name | BOSTON BRACE INTERNATIONAL INC. |
| Doing Business As | NOPCO |
| Type | Prosthetic/Orthotic Supplier |
| Address | 541 Main St Ste 214, Stetson Medical Bldg, Weymouth, MA 02190 |
| Phone Number | 781-849-0247 |
News Archive
Treating people with advanced metastatic kidney cancer using a combination of the immunotherapy drugs nivolumab (Opdivo) and ipilimumab (Yervoy) significantly increased overall survival versus treatment with sunitinib (Sutent) alone, according to new findings from researchers at Memorial Sloan Kettering Cancer Center that were reported today in the New England Journal of Medicine.
Data show that treatment with a single-pill combination of telmisartan, an angiotensin receptor blocker, (ARB) and amlodipine, a calcium channel blocker (CCB) results in significant reductions in blood pressure (BP) in patients with severe hypertension.
NovaBay Pharmaceuticals, Inc. today announced that its lead product candidate was safe and efficacious against the highly contagious skin infection impetigo in a Phase 2a proof-of-concept clinical trial. This dose-ranging study showed that the drug cleared impetigo infections, including those in the trial caused by a drug-resistant strain of bacteria called methicillin-resistant Staphylococcus aureus or MRSA. Impetigo afflicts approximately 1 million people, primarily infants and children, in the United States annually.
The Advanced Wound Management Division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc invites those attending the upcoming Symposium on Advanced Wound Care to visit the Smith & Nephew booth 301, to see the ALLEVYN™ difference with its unique triple-action technology and dynamic moisture control.
As the holidays draw to a close, 29 million Americans with type 2 diabetes had to navigate the minefield of treats, drinks, and dinners. Many patients have stepped up to meet the challenge of moderating their diet, but fewer embrace the benefits of physical activity in controlling their blood sugar.
› Verified 8 days ago
News Archive
Treating people with advanced metastatic kidney cancer using a combination of the immunotherapy drugs nivolumab (Opdivo) and ipilimumab (Yervoy) significantly increased overall survival versus treatment with sunitinib (Sutent) alone, according to new findings from researchers at Memorial Sloan Kettering Cancer Center that were reported today in the New England Journal of Medicine.
Data show that treatment with a single-pill combination of telmisartan, an angiotensin receptor blocker, (ARB) and amlodipine, a calcium channel blocker (CCB) results in significant reductions in blood pressure (BP) in patients with severe hypertension.
NovaBay Pharmaceuticals, Inc. today announced that its lead product candidate was safe and efficacious against the highly contagious skin infection impetigo in a Phase 2a proof-of-concept clinical trial. This dose-ranging study showed that the drug cleared impetigo infections, including those in the trial caused by a drug-resistant strain of bacteria called methicillin-resistant Staphylococcus aureus or MRSA. Impetigo afflicts approximately 1 million people, primarily infants and children, in the United States annually.
The Advanced Wound Management Division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc invites those attending the upcoming Symposium on Advanced Wound Care to visit the Smith & Nephew booth 301, to see the ALLEVYN™ difference with its unique triple-action technology and dynamic moisture control.
As the holidays draw to a close, 29 million Americans with type 2 diabetes had to navigate the minefield of treats, drinks, and dinners. Many patients have stepped up to meet the challenge of moderating their diet, but fewer embrace the benefits of physical activity in controlling their blood sugar.
› Verified 8 days ago
Cvs Pharmacy #01853 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 737 Bridge St, Weymouth, Massachusetts 02191 Phone: (781) 335-3331 | |
Cvs Pharmacy #00043 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 474 Washington St, Weymouth, Massachusetts 02188 Phone: (781) 335-0404 | |
Cvs Pharmacy #02600 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1515 Commercial St, Weymouth, Massachusetts 02189 Phone: (781) 340-1124 | |
Walgreens #6470 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 750 Washington St, Weymouth, Massachusetts 02188 Phone: (781) 331-5301 | |
Wal-mart Pharmacy 10-3200 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 740 Middle St, Weymouth, Massachusetts 02188 Phone: (781) 331-0588 |